{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:32:01Z","timestamp":1790339521428,"version":"4.1.0"},"reference-count":78,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,12,12]]},"DOI":"10.3233\/jad-190624","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T13:39:43Z","timestamp":1573220383000},"page":"1287-1302","source":"Crossref","is-referenced-by-count":8,"title":["Associations Between the Subjective Cognitive Decline-Questionnaire\u2019s Scores, Gray Matter Volume, and Amyloid-\u03b2 Levels"],"prefix":"10.1177","volume":"72","author":[{"given":"Natalia","family":"Valech","sequence":"first","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[{"name":"Barcelona Beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Tort-Merino","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Coll-Padr\u00f3s","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"},{"name":"Institut d\u2019 Investigacions Biom\u00e8diques August pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Olives","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Le\u00f3n","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Falcon","sequence":"additional","affiliation":[{"name":"Barcelona Beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en red (CIBER-BBN), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"},{"name":"Barcelona Beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Institut d\u2019 Investigacions Biom\u00e8diques August pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"},{"name":"Institut d\u2019 Investigacions Biom\u00e8diques August pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190624_ref1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-190624_ref4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-170536","article-title":"The emergence of a new conceptual framework for Alzheimer\u2019s disease","volume":"62","author":"Dubois","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.3233\/JAD-150251","article-title":"Ascertaining subjective cognitive decline: A comparison of approaches and evidence for using an age-anchored reference group.","volume":"48","author":"Tandetnik","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-150180","article-title":"Amyloid and tau biomarkers in subjective cognitive impairment","volume":"47","author":"Colijn","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-014-0539-z","article-title":"Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer\u2019s disease","volume":"264","author":"Jessen","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-190624_ref10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1590\/S1980-5764-2016DN1003002","article-title":"Subjective cognitive decline: The first clinical manifestation of Alzheimer\u2019s disease?","volume":"10","author":"Studart Neto","year":"2016","journal-title":"Dement Neuropsychol"},{"key":"10.3233\/JAD-190624_ref11","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jalz.2007.11.017","article-title":"The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer\u2019s disease","volume":"4","author":"Reisberg","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2013.05.1764","article-title":"Gray matter atrophy pattern in elderly with subjective memory impairment","volume":"10","author":"Peter","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneurol.2011.666","article-title":"Subjective cognition and amyloid deposition imaging: A Pittsburgh compound B positron emission tomography study in normal elderly individuals","volume":"69","author":"Perrotin","year":"2012","journal-title":"Arch Neurol"},{"issue":"S1","key":"10.3233\/JAD-190624_ref14","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.3233\/JAD-150202","article-title":"Evolving evidence for the value of neuroimaging methods and biological markers in subjects categorized with subjective cognitive decline","volume":"48","author":"Lista","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref15","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"Scheef","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/bjp.bp.110.078683","article-title":"Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study","volume":"198","author":"Stewart","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-190624_ref18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-140678","article-title":"Amyloid-\u00df related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults","volume":"43","author":"Hollands","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref19","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.neuropsychologia.2011.04.012","article-title":"Cognition and beta-amyloid in preclinical Alzheimer\u2019s disease: Data from the AIBL study","volume":"49","author":"Pike","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-190624_ref20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"S1","key":"10.3233\/JAD-190624_ref22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-150719","article-title":"Subjective cognitive decline","volume":"48","author":"Tales","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"S1","key":"10.3233\/JAD-190624_ref23","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.3233\/JAD-150154","article-title":"subjective cognitive decline in older adults: An overview of self-report measures used across 19 international research studies","volume":"48","author":"Rabin","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.eurpsy.2008.02.004","article-title":"Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria","volume":"23","author":"Abdulrab","year":"2008","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JAD-190624_ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/NDT.S123428","article-title":"From mild cognitive impairment to subjective cognitive decline: Conceptual and methodological evolution","volume":"13","author":"Cheng","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JAD-190624_ref26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0959259812000172","article-title":"Are subjective cognitive complaints relevant in preclinical Alzheimer\u2019s disease? A review and guidelines for healthcare professionals","volume":"23","author":"Mark","year":"2013","journal-title":"Rev Clin Gerontol"},{"key":"10.3233\/JAD-190624_ref27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5","article-title":"Are memory complaints predictive for dementia? A review of clinical and population-based studies","volume":"15","author":"Jonker","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-190624_ref28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/JGP.0b013e3181df49fb","article-title":"Prevalence and predictors of \u201csubjective cognitive complaints\u201d in the Sydney Memory and Ageing Study","volume":"18","author":"Slavin","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-190624_ref29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1017\/S0033291704003162","article-title":"Memory complaints in a community sample aged 60-64 years: Associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities","volume":"34","author":"Jorm","year":"2004","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-190624_ref30","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-150095","article-title":"Subjective cognitive decline from a phenomenological perspective: A review of the qualitative literature","volume":"48","author":"Buckley","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-132027","article-title":"The subjective cognitive decline questionnaire (SCD-Q): A validation study","volume":"41","author":"Rami","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"S1","key":"10.3233\/JAD-190624_ref32","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3233\/JAD-150117","article-title":"Informant\u2019s perception of subjective cognitive decline helps to discriminate preclinical Alzheimer\u2019s disease from normal aging","volume":"48","author":"Valech","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3233\/JAD-170627","article-title":"Executive and language subjective cognitive decline complaints discriminate preclinical Alzheimer\u2019s disease from normal aging","volume":"61","author":"Valech","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190624_ref34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatry Res"},{"key":"10.3233\/JAD-190624_ref35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J Gerontol"},{"key":"10.3233\/JAD-190624_ref36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology-concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-190624_ref37","first-page":"266","article-title":"The Free and Cued Selective Reminding Test: Evidence of psychometric adequacy","volume":"51","author":"Grober","year":"2009","journal-title":"Psychol Sci Q"},{"key":"10.3233\/JAD-190624_ref38","volume-title":"Boston Naming Test","author":"Kaplan","year":"1983"},{"key":"10.3233\/JAD-190624_ref39","volume-title":"Boston Diagnostic Aphasia Examination-III Edition","author":"Goodglass","year":"2000"},{"key":"10.3233\/JAD-190624_ref40","volume-title":"Visual Object and Space Perception Battery (VOSP).","author":"Warrington","year":"1991"},{"key":"10.3233\/JAD-190624_ref41","unstructured":"Reitan R (1994) Trail MakingTest (TMT). Reitan Neuropsychology Laboratory, USA."},{"key":"10.3233\/JAD-190624_ref42","volume-title":"Multilingual Aphasia Examination Manual","author":"Benton","year":"1976"},{"key":"10.3233\/JAD-190624_ref43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/arclin\/acp027","article-title":"Spanish Multicenter Normative Studies (NEURONORMA project): Methods and sample characteristics","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch Clin Neuropsych"},{"key":"10.3233\/JAD-190624_ref44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.3233\/JAD-190624_ref45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of Dementia by Subjective Memory Impairment: Effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-190624_ref46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer\u2019s Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190624_ref47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer\u2019s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-190624_ref48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jalz.2016.08.010","article-title":"Longitudinal brain structural changes in preclinical Alzheimer\u2019s disease","volume":"13","author":"Pegueroles","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid \u03b2-amyloid 1-42 values have thicker cortex in Alzheimer\u2019s disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-190624_ref50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190624_ref51","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.neurobiolaging.2005.10.010","article-title":"Volume reduction of the entorhinal cortex in subjective memory impairment","volume":"27","author":"Jessen","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190624_ref52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2012.12.011","article-title":"Hippocampus-precuneus functional connectivity as an early sign of Alzheimer\u2019s disease: A preliminary study using structural and functional magnetic resonance imaging data","volume":"1495","author":"Kim","year":"2013","journal-title":"Brain Res"},{"key":"10.3233\/JAD-190624_ref53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.neuro.27.070203.144130","article-title":"The medial temporal lobe","volume":"27","author":"Squire","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-190624_ref54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0959259809990426","article-title":"Patterns of brain atrophy on magnetic resonance imaging and the boundary between ageing and Alzheimer\u2019s disease","volume":"19","author":"Sullivan","year":"2017","journal-title":"Rev Clin Gerontol"},{"key":"10.3233\/JAD-190624_ref55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0197-4580(01)00217-2","article-title":"Effects of age on tissues and regions of the cerebrum and cerebellum","volume":"22","author":"Jernigan","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190624_ref56","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/brain\/awq187","article-title":"Larger temporal volume in elderly with high versus low beta-amyloid deposition","volume":"133","author":"Ch\u00e9telat","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JAD-190624_ref57","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.neurobiolaging.2007.05.005","article-title":"Resistance to Alzheimer\u2019s pathology is associated with nuclear hypertrophy in neurons","volume":"28","author":"Riudavets","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190624_ref58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e3181b01077","article-title":"The Nun study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life","volume":"73","author":"Iacono","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/gps.2207","article-title":"Subjective cognitive impairment: Increased prefrontal cortex activation compared to controls during an encoding task","volume":"24","author":"Rodda","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-190624_ref60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.eurpsy.2010.07.003","article-title":"Subjective cognitive impairment: Functional MRI during a divided attention task","volume":"26","author":"Rodda","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JAD-190624_ref61","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-190624_ref62","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-190624_ref63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.0000000000001712","article-title":"Subjective cognitive concerns, amyloid-\u03b2, and neurodegeneration in clinically normal elderly","volume":"85","author":"Amariglio","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref64","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/cns.12395","article-title":"Biochemical and neuroimaging studies in subjective cognitive decline: Progress and perspectives","volume":"21","author":"Sun","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-190624_ref65","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1532-5415.2012.03956.x","article-title":"Predicting Alzheimer\u2019s disease: Neuropsychological tests, self reports, and informant reports of cognitive difficulties","volume":"60","author":"Rabin","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-190624_ref66","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.55.11.1724","article-title":"The value of informant versus individual\u2019s complaints of memory impairment in early dementia","volume":"55","author":"Carr","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0390-y","article-title":"Subjective Cognitive Impairment Cohort (SCIENCe): Study design and first results","volume":"10","author":"Slot","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190624_ref68","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Ovid: Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"89","author":"Hedden","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref69","doi-asserted-by":"crossref","first-page":"e79378","DOI":"10.1371\/journal.pone.0079378","article-title":"Executive function changes before memory in preclinical Alzheimer\u2019s pathology: A prospective, cross-sectional, case control study","volume":"8","author":"Harrington","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190624_ref70","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints","volume":"81","author":"Van Harten","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-190624_ref71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/S1355617708080302","article-title":"Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer\u2019s disease","volume":"14","author":"Grober","year":"2008","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-190624_ref72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1525740113520322","article-title":"Early detection of cognitive-linguistic change associated with mild cognitive impairment","volume":"35","author":"Fleming","year":"2014","journal-title":"Commun Disord Q"},{"key":"10.3233\/JAD-190624_ref73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/17549500903137256","article-title":"Temporal parameters of spontaneous speech in Alzheimer\u2019s disease","volume":"12","author":"Hoffmann","year":"2010","journal-title":"Int J Speech Lang Pathol"},{"key":"10.3233\/JAD-190624_ref74","doi-asserted-by":"crossref","first-page":"S602","DOI":"10.1016\/j.jalz.2011.05.1709","article-title":"Language in the preclinical stage of Alzheimer\u2019s Disease: Content and complexity in biographical narratives","volume":"7","author":"Schr\u00f6der","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190624_ref75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S1355617707070609","article-title":"Linguistic changes in verbal expression: A preclinical marker of Alzheimer\u2019s disease","volume":"13","author":"Cuetos","year":"2007","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-190624_ref76","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1037\/neu0000246","article-title":"Biomarker validation of a decline in semantic processing in preclinical Alzheimer\u2019s disease","volume":"30","author":"Papp","year":"2016","journal-title":"Neuropsychology"},{"key":"10.3233\/JAD-190624_ref77","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/070674370805300604","article-title":"Memory and cognition in preclinical dementia: What we know and what we do not know","volume":"53","author":"B\u00e4ckman","year":"2008","journal-title":"Can J Psychiatry"},{"key":"10.3233\/JAD-190624_ref78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","article-title":"Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community","volume":"73","author":"Petersen","year":"2016","journal-title":"JAMA Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:06Z","timestamp":1777370826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":78,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190624","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}